Farhana Latif MD
Heart Failure & Transplantation
Assistant Professor, Medicine, Columbia University College of Phys & Surg
622 W 168th StPh-3 Stem 137New York, NY 10032
Fax+1 212-342-3414
Overview of Dr. Latif
Dr. Farhana Latif is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albany Medical College and has been in practice 28 years. She is one of 754 doctors at New York-Presbyterian Hospital and one of 356 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. She has more than 100 publications and over 500 citings.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2002 - 2007- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
Albany Medical CollegeClass of 1998
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2001 - 2027
NJ State Medical License 2008 - 2009
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
Publications & Presentations
PubMed
- 1 citationsA molecular reappraisal of quilty lesions: Insights from tissue and circulating biomarkers in heart transplantation.Andrea Fernandez Valledor, Cathrine M Moeller, Adi Hertz, Daniel Oren, Ilan Richter
The Journal of Heart and Lung Transplantation. 2026-05-01 - Heart Transplantation and Cancer Risk in a BRCA1 Breast Cancer Survivor.Laura Noteware, Eleanor Keller, Dor Lotan, Ersilia M DeFilippis, Carolyn Hennecken
JACC. Case Reports. 2026-02-25 - Increased Incidence of De Novo Malignancies Compared With Malignancy Recurrences in Survivors of Cancer Undergoing Heart Transplantation.Jayant Raikhelkar, Daniel Oren, Stephanie Golob, Jaya Batra, Sarah Godfrey
Journal of the American Heart Association. 2026-02-17
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
